Fidelity Advisor Series VII - Fidelity Advisor Biotechnology Fund logo

Fidelity Advisor Series VII - Fidelity Advisor Biotechnology Fund(NASDAQMUTFUND) FBTIX

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2001)+978%
5 Year+80%
1 Year+30%
1 Month-5%
$50.15
+1.75%
+0.86Today
Fidelity Advisor Series VII - Fidelity Advisor Biotechnology Fund last closing stock price
MetricPriceDate
Last closeUSD 50.152026-10-15
Fidelity Advisor Series VII - Fidelity Advisor Biotechnology Fund stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+1.77%USD 49.282026-10-08
1 month-5%USD 52.792026-09-15
3 month-1.55%USD 50.942026-07-17
Year to date+21.58%USD 41.252025-12-31
1 year+29.56%USD 38.712025-10-15
3 year+111.4%USD 23.722023-10-16
5 year+79.83%USD 27.892021-10-15
Since inception+977.55%USD 4.652001-01-12

Fidelity Advisor Series VII - Fidelity Advisor Biotechnology Fund Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$50.15

Volume

N/A

Open

$49.29

Previous Close

$50.15

Daily Range

$50.15 - $50.15

52-Week Range

$50.15 - $50.15

Estimated Earnings Date

N/A

FBTIX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Fidelity Advisor Series VII - Fidelity Advisor Biotechnology Fund

The Fidelity Advisor Biotechnology Fund focuses on investing in biotechnology-related companies, aiming to capitalize on advancements in the sector. This fund primarily allocates at least 80% of its assets to stocks of companies involved in biotechnology, including both U.S. and foreign entities.

Products and Services
  • Invests in common stocks of biotechnology companies
  • Focuses on companies involved in scientific and technological breakthroughs
  • Utilizes comprehensive fundamental analysis for investment decisions
Growth Outlook
  • Biotechnology sector expected to grow significantly in the coming years
  • Increased demand for innovative healthcare solutions drives market potential
  • Technological advancements continue to enhance investment opportunities
Financial Highlights
  • Market capitalization stands at approximately $2.31 billion
  • Recent dividend yield is around 1.07%
  • Stock price range over the past year is $34.27 to $57.68
The Fidelity Advisor Biotechnology Fund is structured as a non-diversified fund, allowing for a concentrated investment strategy. The focus on biotechnology positions the fund to benefit from the rapid advancements in healthcare and technology. With a solid market capitalization and a competitive dividend yield, the fund presents an intriguing option for investors interested in the biotechnology sector. The ongoing growth in demand for innovative solutions further enhances the fund's potential for future success.
AI Generated • Sep 18, 2026

Industry

Capital Markets

Sector

Financials

Headquarters

Boston, MA 2210, US

FBTIX Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

0

Volume

N/A

Avg. Volume

0

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,649.66-0.01%
^DJIDJI
$51,876.16-0.01%
^IXICNASDAQ
$26,111.34-0.02%
BTCBitcoin
$81,339.00-0.01%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$89.85-5.79%
NVDANvidia
$214.13-1.43%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$93.67-12.74%
CCCCCC Intelligent Solutions
$7.61-0.26%

Questions About FBTIX

What is the current price of Fidelity Advisor Series VII - Fidelity Advisor Biotechnology Fund?

Fidelity Advisor Series VII - Fidelity Advisor Biotechnology Fund is trading at $50.15 per share.

What is the 52-week range for Fidelity Advisor Series VII - Fidelity Advisor Biotechnology Fund?

Over the past 52 weeks, Fidelity Advisor Series VII - Fidelity Advisor Biotechnology Fund has traded between $50.15 and $50.15.

How much debt does Fidelity Advisor Series VII - Fidelity Advisor Biotechnology Fund have?

Fidelity Advisor Series VII - Fidelity Advisor Biotechnology Fund total debt is unavailable.

How much cash does Fidelity Advisor Series VII - Fidelity Advisor Biotechnology Fund have on hand?

Fidelity Advisor Series VII - Fidelity Advisor Biotechnology Fund does not have cash on hand data available.

What is Fidelity Advisor Series VII - Fidelity Advisor Biotechnology Fund’s dividend yield?

Fidelity Advisor Series VII - Fidelity Advisor Biotechnology Fund does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services